Search
for
Sort by
Research 121–150 of 162
- Hormonal Contraceptives and Dermatology
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility
- Complications of Subcutaneous Contraception: A Review
- Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment
- Intermittent Low-Dose Finasteride Administration Is Effective for Treatment of Hirsutism in Adolescent Girls: A Pilot Study
- The Hirsute Woman: Challenges in Evaluation and Management
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Ovarian surgery for symptom relief in women with polycystic ovary syndrome
- Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- Oriental herbal medicine and moxibustion for polycystic ovary syndrome
- Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea
- A Comprehensive Review of Acne Vulgaris
- Menopausal Acne – Challenges And Solutions
- National consensus on the management of patients with hyperandrogenism (2016)
- Choice of treatment for women with polycystic ovary syndrome
- FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
- The Role of Probiotics and Synbiotics on Hirsutism
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Skin manifestations of polycystic ovary syndrome
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Physiology of Testicular Function
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Skin Androgen-Related Disorders: Hormonal Treatment
- Photobiomodulation Literature Watch January 2022